Sander Kersten

Personal Home Page

http://kersten.4t.com/

Articles in Scholarly Journals [Incomplete List]

  1. The PPARγ ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARγ in the subcutaneous adipose tissue
    British Journal of Nutrition, vol. 99, no. 03, 2008
  2. Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
    PPAR Research, vol. 2008, Article ID 132960, 11 pages, 2008
  3. Effect of Synthetic Dietary Triglycerides: A Novel Research Paradigm for Nutrigenomics
    PLoS ONE, vol. 3, no. 2, p. e1681, 2008
  4. Peroxisome Proliferator-Activated Receptor   Protects against Obesity-Induced Hepatic Inflammation
    Endocrinology, vol. 148, no. 6, pp. 2753–2763, 2007
  5. Angptl4 Upregulates Cholesterol Synthesis in Liver via Inhibition of LPL- and HL-Dependent Hepatic Cholesterol Uptake
    Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 11, pp. 2420–2427, 2007
  6. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD
    European Respiratory Journal, vol. 30, no. 2, pp. 245–252, 2007
  7. Design guidelines for the development of digital nutrigenomics learning material for heterogeneous target groups
    AJP: Advances in Physiology Education, vol. 31, no. 1, pp. 67–75, 2007
  8. Genome-wide analysis of PPAR  activation in murine small intestine
    Physiological Genomics, vol. 30, no. 2, pp. 192–204, 2007
  9. Comprehensive Analysis of PPARa-Dependent Regulation of Hepatic Lipid Metabolism by Expression Profiling
    PPAR Research, vol. 2007, Article ID 26839, 13 pages, 2007
  10. PPARS and Obesity
    PPAR Research, vol. 2007, Article ID 78475, 1 pages, 2007
  11. PPARs, Obesity, and Inflammation
    PPAR Research, vol. 2007, Article ID 95974, 10 pages, 2007
  12. The Interleukin-1 receptor antagonist is a direct target gene of PPARa in liver?
    Journal of Hepatology, vol. 46, no. 5, pp. 869–877, 2007
  13. Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors
    Cellular and Molecular Life Sciences, vol. 64, no. 9, pp. 1145–1157, 2007
  14. PPARa and dyslipidemia
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1771, no. 8, pp. 961–971, 2007
  15. Exploration of PPAR functions by microarray technology—A paradigm for nutrigenomics
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1771, no. 8, pp. 1046–1064, 2007
  16. PPAR? activity in subcutaneous abdominal fat tissue and fat mass gain during short-term overfeeding
    International Journal of Obesity, vol. 30, no. 2, Article ID 0803146, 5 pages, 2006
  17. Sulfonylureas and Glinides Exhibit Peroxisome Proliferator-Activated Receptor   Activity: A Combined Virtual Screening and Biological Assay Approach
    Molecular Pharmacology, vol. 71, no. 2, pp. 398–406, 2006
  18. Peroxisome Proliferator-Activated Receptor- -Null Mice Have Increased White Adipose Tissue Glucose Utilization, GLUT4, and Fat Mass: Role in Liver and Brain
    Endocrinology, vol. 147, no. 9, pp. 4067–4078, 2006
  19. Peroxisome Proliferator-Activated Receptor � Mediates the Effects of High-Fat Diet on Hepatic Gene Expression
    Endocrinology, vol. 147, no. 3, pp. 1508–1516, 2005
  20. The G0/G1 switch gene 2 is a novel PPAR target gene
    Biochemical Journal, vol. 392, no. 2, p. 313, 2005
  21. Regulation of lipid metabolism via angiopoietin-like proteins
    Biochemical Society Transactions, vol. 33, no. 5, p. 1059, 2005
  22. Promoter Rearrangements Cause Species-specific Hepatic Regulation of the Glyoxylate Reductase/Hydroxypyruvate Reductase Gene by the Peroxisome Proliferator-activated Receptor  
    Journal of Biological Chemistry, vol. 280, no. 25, pp. 24143–24152, 2005
  23. The Fasting-induced Adipose Factor/Angiopoietin-like Protein 4 Is Physically Associated with Lipoproteins and Governs Plasma Lipid Levels and Adiposity
    Journal of Biological Chemistry, vol. 281, no. 2, pp. 934–944, 2005
  24. Angiopoietin-like-4 is a potential angiogenic mediator in arthritis
    Clinical Immunology, vol. 115, no. 1, pp. 93–101, 2005
  25. Peroxisome proliferator-activated receptor a target genes
    Cellular and Molecular Life Sciences (CMLS), vol. 61, no. 4, pp. 393–416, 2004
  26. PPAR? governs glycerol metabolism
    Journal of Clinical Investigation, vol. 114, no. 1, pp. 94–103, 2004
  27. In vivo activation of PPAR target genes by RXR homodimers
    The EMBO Journal, vol. 23, no. 10, Article ID 7600209, 8 pages, 2004
  28. The Direct Peroxisome Proliferator-activated Receptor Target Fasting-induced Adipose Factor (FIAF/PGAR/ANGPTL4) Is Present in Blood Plasma as a Truncated Protein That Is Increased by Fenofibrate Treatment
    Journal of Biological Chemistry, vol. 279, no. 33, pp. 34411–34420, 2004
  29. Opinion: Nutrigenomics: goals and strategies
    Nature Reviews Genetics, vol. 4, no. 4, Article ID nrg1047, 7 pages, 2003
  30. Effects of fatty acids on gene expression: role of peroxisome proliferator-activated receptor a, liver X receptor a and sterol regulatory ­element-binding protein-1c
    Proceedings of the Nutrition Society, vol. 61, no. 3, pp. 371–374, 2002
  31. Mechanisms of nutritional and hormonal regulation of lipogenesis
    EMBO Reports, vol. 2, no. 4, pp. 282–286, 2001
  32. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism
    The FASEB Journal, vol. 15, no. 11, pp. 1971–1978, 2001
  33. Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target Gene
    Journal of Biological Chemistry, vol. 275, no. 37, pp. 28488–28493, 2000
  34. Nature, vol. 405, no. 6785, pp. 421–424, 2000
  35. Steroid and nuclear receptors Villefranche-sur-Mer, France, May 25–27, 1999
    The EMBO Journal, vol. 18, no. 22, Article ID 7592021, 9 pages, 1999
  36. Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
    Journal of Clinical Investigation, vol. 103, no. 11, pp. 1489–1498, 1999